Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Dabbs

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 21, 2015
A Comparison of Breast Cancer Multianalyte Assays With Algorithmic Analyses (MAAA) for Their Net Predictive/Prognostic ValueDavid J Dabbs
American Journal of Clinical Pathology|February 21, 2008
Immunohistochemical protocols: back to the futureDavid J Dabbs
The Breast Journal|May 6, 2004
The optimal number of sentinel lymph nodes for focused pathologic examinationDavid J Dabbs, Ronald Johnson
Histopathology|January 16, 2016
Biomarker assessment and molecular testing for prognostication in breast cancerZuzana Kos, David J Dabbs
Breast Cancer Research : BCR|October 4, 2008
Luminal B breast tumors are not HER2 positiveRohit Bhargava, David J Dabbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Cancer of unknown primary origin: using ancillary techniques with cautionRohit Bhargava, David J Dabbs
Breast Cancer Research and Treatment|April 11, 2017
Magee equations and oncotype DX<sup>®</sup>-a perspectiveRohit Bhargava, David J Dabbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Oncotype DX test on unequivocally HER2-positive cases: potential for harmRohit Bhargava, David J Dabbs
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 6, 2022
Avoiding "False Positive" and "False Negative" Immunohistochemical Results in Breast PathologyZaibo Li, David J Dabbs
American Journal of Clinical Pathology|December 22, 2010
Fixation time does not affect the expression of estrogen receptorDavid J Dabbs, Rohit Bhargava
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Clinical Advances in Hematology & Oncology : H&O|July 21, 2015
A Comparison of Breast Cancer Multianalyte Assays With Algorithmic Analyses (MAAA) for Their Net Predictive/Prognostic ValueDavid J Dabbs
American Journal of Clinical Pathology|February 21, 2008
Immunohistochemical protocols: back to the futureDavid J Dabbs
The Breast Journal|May 6, 2004
The optimal number of sentinel lymph nodes for focused pathologic examinationDavid J Dabbs, Ronald Johnson
Histopathology|January 16, 2016
Biomarker assessment and molecular testing for prognostication in breast cancerZuzana Kos, David J Dabbs
Breast Cancer Research : BCR|October 4, 2008
Luminal B breast tumors are not HER2 positiveRohit Bhargava, David J Dabbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Cancer of unknown primary origin: using ancillary techniques with cautionRohit Bhargava, David J Dabbs
Breast Cancer Research and Treatment|April 11, 2017
Magee equations and oncotype DX<sup>®</sup>-a perspectiveRohit Bhargava, David J Dabbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Oncotype DX test on unequivocally HER2-positive cases: potential for harmRohit Bhargava, David J Dabbs
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 6, 2022
Avoiding "False Positive" and "False Negative" Immunohistochemical Results in Breast PathologyZaibo Li, David J Dabbs
American Journal of Clinical Pathology|December 22, 2010
Fixation time does not affect the expression of estrogen receptorDavid J Dabbs, Rohit Bhargava
Pageof 13